How should ketorolac be dosed in an adult without renal, hepatic, or bleeding risk, and what dose adjustments are required for patients aged ≥ 65 years or with moderate renal impairment?

Ketorolac Dosing in Adults

Standard Dosing for Adults <65 Years Without Renal Impairment

For adults under 65 years of age without renal, hepatic, or bleeding risk, administer ketorolac 30 mg IV every 6 hours (maximum 120 mg/day) or 60 mg IM as a single dose, with treatment duration not exceeding 5 days. 1

Intravenous Administration

• 30 mg IV bolus over at least 15 seconds, repeated every 6 hours 1
• Maximum daily dose: 120 mg 1
• Analgesic effect begins in approximately 30 minutes with maximum effect at 1-2 hours 1
• Duration of effect: 4-6 hours 1

Intramuscular Administration

• 60 mg IM as single dose for patients <65 years 1
• Administer slowly and deeply into muscle 1

Important Dosing Context

While research suggests that 10 mg IV may represent the analgesic ceiling dose with equivalent pain relief to higher doses 2, 3, the FDA-approved dosing remains 30 mg IV for standard adult patients 1. Emergency physicians commonly prescribe above this ceiling dose, with 84.6% of IV administrations being 30 mg 4, though this may offer no additional analgesic benefit while potentially increasing adverse effects 5.

Mandatory Dose Reductions for High-Risk Populations

Patients ≥65 Years of Age

Reduce the dose by 50% for all elderly patients regardless of other risk factors. 1

• IV dosing: 15 mg every 6 hours (maximum 60 mg/day) 1
• IM dosing: 30 mg as single dose 1
• Elderly patients exhibit reduced drug clearance and increased risk of adverse events 6, 5

Patients with Moderate Renal Impairment

Use the same reduced dosing as elderly patients: 15 mg IV every 6 hours (maximum 60 mg/day). 1

• Renal insufficiency causes accumulation of ketorolac in plasma 6
• Risk of acute renal failure increases with renal impairment, though typically reversible after discontinuation 5
• Correct hypovolemia prior to administration 1

Patients <50 kg (110 lbs)

Apply the same dose reduction: 15 mg IV every 6 hours (maximum 60 mg/day). 1

Critical Duration Limitation

Never exceed 5 days of ketorolac therapy regardless of route or indication. 1, 5

• Switch to alternative analgesics as soon as possible 1
• Risk of adverse events increases significantly with prolonged therapy beyond 5 days 5
• Consider supplementing with low-dose opioids for breakthrough pain rather than increasing ketorolac dose or frequency 1

Absolute Contraindications

Do not administer ketorolac in the following situations: 7, 5

• Active peptic ulcer disease or gastrointestinal bleeding 7, 5
• History of gastrointestinal hemorrhage 7
• Severe renal impairment (CrCl <30 mL/min) 7
• Active bleeding or high risk for bleeding complications 7
• Concurrent anticoagulation therapy 7
• Hypersensitivity to aspirin or other NSAIDs 5
• Pregnancy, labor, delivery, or breastfeeding 5

High-Risk Populations Requiring Caution

Gastrointestinal Risk Factors

Use extreme caution or avoid in patients with: 7

• Age ≥60 years 7
• History of peptic ulcer disease 7
• Significant alcohol use (≥2 drinks/day) 7
• Concurrent use of anticoagulants, antiplatelets, SSRIs, SNRIs, or glucocorticoids 7
• Consider prophylactic PPI in high-risk patients 7

Renal Risk Factors

Monitor closely in patients with: 7

• Age ≥60 years 7
• Compromised fluid status or dehydration 7
• Concurrent nephrotoxic medications (cyclosporine, cisplatin) 7
• Pre-existing renal insufficiency 7

Cardiovascular Risk Factors

Exercise caution in patients with: 7

• History of cardiovascular disease 7
• Hypertension (may worsen blood pressure control) 7
• Heart failure (can precipitate or worsen HF) 7

Monitoring Requirements

Establish baseline values before initiating therapy: 7

• Blood pressure 7
• BUN and creatinine 7
• Liver function tests (alkaline phosphatase, LDH, SGOT, SGPT) 7
• Complete blood count 7
• Fecal occult blood 7

Repeat monitoring every 3 months during therapy to ensure lack of toxicity. 7

Discontinuation Criteria

Stop ketorolac immediately if: 7

• BUN or creatinine doubles 7
• Hypertension develops or worsens 7
• Liver function tests increase >3 times upper limit of normal 7
• Peptic ulcer or gastrointestinal hemorrhage occurs 7

Critical Drug Interaction: Avoiding NSAID Stacking

Wait 6-8 hours after the last ibuprofen dose before administering ketorolac to allow adequate drug clearance. 8

• Never combine multiple NSAIDs concurrently 8
• Toxicities are additive without providing additional analgesic benefit 8
• Ibuprofen has a half-life of approximately 2 hours with peak levels at 1-2 hours 8
• Consider acetaminophen or opioid analgesics as alternatives during the waiting period 8

Alternative Analgesic Strategies

For breakthrough pain, supplement with low-dose opioids rather than increasing ketorolac dose or frequency. 1

• Opioid analgesics are safe and effective alternatives to NSAIDs 7, 8
• Acetaminophen can be alternated with ketorolac every 3 hours for continuous coverage 8
• Acetaminophen 650 mg every 4-6 hours (maximum 3-4 grams/day) has non-overlapping toxicity profile 8

Pharmaceutical Incompatibilities

Do not mix ketorolac in a syringe with: 1

• Morphine sulfate 1
• Meperidine hydrochloride 1
• Promethazine hydrochloride 1
• Hydroxyzine hydrochloride 1

This combination results in precipitation of ketorolac from solution 1.